Quest Diagnostics Inc(DGX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 24.52 | EPS (ttm) | 9.43 | Insider Own | 0.48% | Shs Outstand | 110.0M | Perf Week | -4.01% |
| Market Cap | 25.51B | Forward P/E | 19.17 | EPS next Y | 7.74% | Insider Trans | -9% | Shs Float | 109.8M | Perf Month | -2.68% |
| Enterprise Value | 31.65B | PEG | 1.92 | EPS next Q | 2.87 | Inst Own | 97.92% | Short Float | 3.02% | Perf Quarter | 13.43% |
| Income | 1.06B | P/S | 2.21 | EPS this Y | 13.62% | Inst Trans | 0.93% | Short Ratio | 3.48 | Perf Half Y | 15.25% |
| Sales | 11.56B | P/B | 3.38 | EPS next 5Y | 9.96% | ROA | 6.43% | Short Interest | 3.32M | Perf YTD | 33.2% |
| Book/sh | 68.33 | P/C | 40.75 | EPS past 3/5Y | 3.08% -3.64% | ROE | 14.35% | 52W High | -6.49% ($247.19) | Perf Year | 28.31% |
| Cash/sh | 5.67 | P/FCF | 18.91 | Sales past 3/5Y | 3.74% 3.18% | ROIC | 7.72% | 52W Low | 35.03% ($171.18) | Perf 3Y | 81.97% |
| Dividend Est. | $3.33 (1.44%) | EV/EBITDA | 13.99 | EPS Y/Y TTM | 12.51% | Gross Margin | 31.87% | Volatility(W/M) | 2.18% 2% | Perf 5Y | 49.18% |
| Dividend TTM | 3.32 | EV/Sales | 2.74 | Sales Y/Y TTM | 9.87% | Oper. Margin | 14.56% | ATR (14) | 5.23 | Perf 10Y | 185.64% |
| Dividend Ex-Date | 2026/10/6 | Quick Ratio | 1.46 | EPS Q/Q | 14.54% | Profit Margin | 9.15% | RSI (14) | 41.35 | Recom | 2.2 |
| Dividend Gr. 3/5Y | 6.62% 7.39% | Current Ratio | 1.59 | Sales Q/Q | 10.21% | SMA20 | -3.42% ($239.32) | Beta | 0.54 | Target Price | $249.79 |
| Payout | 36.6% | Debt/Eq | 0.85 | Earnings | 2026/7/23 | SMA50 | 0.98% ($228.9) | Rel Volume | 1.13 | Prev Close | $235.46 |
| Employees | 57000 | LT Debt/Eq | 0.82 | EPS/Sales Surpr. | 10.53% 2.36% | SMA200 | 14.54% ($201.8) | Avg Volume(3M) | 0.95M | Price | $231.14 |
| IPO | 1996/12/17 | Option/Short | Yes/Yes | Trades | 15246 | Volume | 1,075,654 | Change | -1.83% |
Company
DGX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🔬 Quest Diagnostics (DGX) is a leading medical diagnostics company that reliably delivers comprehensive, high-quality clinical diagnostic information services and advanced precision testing solutions for early disease detection to a large number of patients and major healthcare institutions across the United States.
Over the past 1 year, on the higher side
6% below its 1-year high.
Upcoming eventsNext ex-dividend (upcoming)
Ex-dividend October 6
DGX makes money exceptionally well
14.56% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +13.6% this year.
Tap to view numbers
The price looks about right
Trading at 24.5 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +82.0% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.44% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 97.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SASS 0.05%
IHF 0.04%
PINK 0.03%
JDVL 0.02%
FTDS 0.02%It ranks #4 in the industry
Based on market cap of $26B.
DGX $26B PER 24.5
TMO $223B PER 32.5
DHR $141B PER 35.6
NTRA $47B PER -
FAQ
What kind of company is DGX?
DGX belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of DGX?
The market cap of DGX is approximately $25.5B, ranking 514 within its sector.
Does DGX pay dividends?
DGX has a dividend yield of approximately 1.44%, with an annual dividend of $3.33.
What is the P/E ratio of DGX?
DGX has a P/E ratio of approximately 24.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for DGX?
DGX has recorded a 52-week high of $247.19 and a low of $171.18.
